Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 43 matching records.
43 results — page 1 of 2
- Level BClinical TrialPubMed
Autologous SVF therapy modulates neuroinflammation in ALS: phase I trial demonstrating safety and CSF biomarker dynamics.
Clinical Trial with a reported sample of 26 on Neuroinflammation, Immune Modulation, published in Front Aging Neurosci (2026) — summary generated from the PubMed abstract.
- 2026
- n = 26
Front Aging Neurosci - Level BClinical TrialPubMed
Decellularised Corneal Stromal Lamina With or Without Autologous Adipose-Derived Adult Stem Cells for Advanced Keratoconus: 1-Year Results of a Phase I/IIa Clinical Trial.
Clinical Trial with a reported sample of 5, published in Clin Exp Ophthalmol (2026) — summary generated from the PubMed abstract.
- 2026
- n = 5
Clin Exp Ophthalmol - Level BClinical TrialEurope PMC
Safety of autologous nucleus pulposus cell transplantation with fibrin glue following endoscopic discectomy in chronic low back pain: a preliminary phase I trial
Clinical Trial on Back Pain, Disc Degeneration, published in BMC Musculoskelet Disord (2025) — summary generated from the PubMed abstract.
- 2025
BMC Musculoskelet Disord - Level BClinical TrialPubMed
Efficacy and safety of autologous adipose-derived stem cells in subjects with moderate to severe atopic dermatitis: a multicenter, randomized, single-blind, placebo-controlled, phase 2 trial.
Clinical Trial with a reported sample of 114 on Scar, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
- n = 114
Stem Cell Res Ther - Level BClinical TrialEurope PMC
Cell-Based Therapy by Autologous Bone Marrow-Derived Mononuclear Cells for Bone Augmentation of Plate-Stabilized Proximal Humeral Fractures: A Multicentric, Randomized, Open Phase IIa study
Clinical Trial with a reported sample of 56 on Shoulder, published in Stem Cells Transl Med (2024) — summary generated from the PubMed abstract.
- 2024
- n = 56
Stem Cells Transl Med12 citations - Level BClinical TrialPubMed
Safety and efficacy of autologous adipose tissue-derived stem cell transplantation in aging-related low-grade inflammation patients: a single-group, open-label, phase I clinical trial.
Clinical Trial on Type 2 Diabetes, Neuroinflammation, Immune Modulation, published in Trials (2024) — summary generated from the PubMed abstract.
- 2024
Trials - Level BClinical TrialEurope PMC
Stem cell therapy in diabetic men with erectile dysfunction: a 24-month follow-up of safety and efficacy of two intracavernous autologous bone marrow derived mesenchymal stem cells injections, an open label phase 2 clini
Clinical Trial, published in Basic Clin Androl (2024) — summary generated from the PubMed abstract.
- 2024
Basic Clin Androl2 citations - Level BClinical TrialPubMed
Safety and feasibility of autologous adipose-derived stromal vascular fraction in the treatment of keloids: a phase one randomized controlled pilot trial.
Clinical Trial with a reported sample of 8 on Scar, published in Am J Stem Cells (2023) — summary generated from the PubMed abstract.
- 2023
- n = 8
Am J Stem Cells5 citations - Level ARandomized Controlled TrialPubMed
Clinical Efficacy and Safety of the Intra-articular Injection of Autologous Adipose-Derived Mesenchymal Stem Cells for Knee Osteoarthritis: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial.
Randomized Controlled Trial with a reported sample of 261 on Knee Osteoarthritis, Osteoarthritis, Cartilage Damage, published in Am J Sports Med (2023) — summary generated from the PubMed abstract.
- 2023
- n = 261
Am J Sports Med91 citations - Level BClinical TrialEurope PMC
Autologous mesenchymal stromal cells embedded with Tissucol Duo ® for prevention of air leak after anatomical lung resection: results of a prospective phase I/II clinical trial with long-term follow-up
Clinical Trial, published in Stem Cell Res Ther (2023) — summary generated from the PubMed abstract.
- 2023
Stem Cell Res Ther2 citations - Level BClinical TrialPubMed
Safety and efficacy of autologous, adipose-derived mesenchymal stem cells in patients with rheumatoid arthritis: a phase I/IIa, open-label, non-randomized pilot trial.
Clinical Trial on Autoimmune Research, published in Stem Cell Res Ther (2022) — summary generated from the PubMed abstract.
- 2022
Stem Cell Res Ther39 citations - Level BRandomized Controlled TrialPubMed
Long-term Safety of Treatment with Autologous Mesenchymal Stem Cells in Patients with Radiation-Induced Xerostomia: Primary Results of the MESRIX Phase I/II Randomized Trial.
Randomized Controlled Trial with a reported sample of 15, published in Clin Cancer Res (2022) — summary generated from the PubMed abstract.
- 2022
- n = 15
Clin Cancer Res25 citations - Level BRandomized Controlled TrialPubMed
Autologous cultured adipose derived mesenchymal stem cells combined with hyaluronic acid hydrogel in the treatment of discogenic low back pain: a study protocol for a phase II randomised controlled trial.
Randomized Controlled Trial on Back Pain, Disc Degeneration, published in BMJ Open (2022) — summary generated from the PubMed abstract.
- 2022
BMJ Open6 citations - Level BClinical TrialPubMed
Durable Response in Patients With Refractory Fistulizing Perianal Crohn's Disease Using Autologous Mesenchymal Stem Cells on a Dissolvable Matrix: Results from the Phase I Stem Cell on Matrix Plug Trial.
Clinical Trial with a reported sample of 20 on Autoimmune Research, published in Dis Colon Rectum (2022) — summary generated from the PubMed abstract.
- 2022
- n = 20
Dis Colon Rectum15 citations - Level BClinical TrialEurope PMC
Intravitreal autologous mesenchymal stem cell transplantation: a non-randomized phase I clinical trial in patients with retinitis pigmentosa
Clinical Trial with a reported sample of 14, published in Stem Cell Res Ther (2021) — summary generated from the PubMed abstract.
- 2021
- n = 14
Stem Cell Res Ther60 citations - Level BClinical TrialEurope PMC
Phase I/II Clinical Trial of Autologous Activated Platelet-Rich Plasma (aaPRP) in the Treatment of Severe Coronavirus Disease 2019 (COVID-19) Patients
Clinical Trial with a reported sample of 19 on Cardiovascular Disease, Chronic Inflammation, published in Int J Inflam (2021) — summary generated from the PubMed abstract.
- 2021
- n = 19
Int J Inflam6 citations - Level BClinical TrialPubMed
Intracerebral transplantation of autologous adipose-derived stem cells for chronic ischemic stroke: A phase I study.
Clinical Trial on Stroke Research, published in J Tissue Eng Regen Med (2021) — summary generated from the PubMed abstract.
- 2021
J Tissue Eng Regen Med24 citations - Level BClinical TrialPubMed
Autologous Infusion of Bone Marrow and Mesenchymal Stromal Cells in Patients with Chronic Obstructive Pulmonary Disease: Phase I Randomized Clinical Trial.
Clinical Trial on Chronic Inflammation, published in Int J Chron Obstruct Pulmon Dis (2021) — summary generated from the PubMed abstract.
- 2021
Int J Chron Obstruct Pulmon Dis11 citations - Level BClinical TrialEurope PMC
Long-Term Follow-up of Autologous Fibroblast Transplantation for Facial Contour Deformities, A Non-Randomized Phase IIa Clinical Trial
Clinical Trial with a reported sample of 37 on Scar, Skin Aging, published in Cell J (2020) — summary generated from the PubMed abstract.
- 2020
- n = 37
Cell J8 citations - Level BClinical TrialPubMed
Two phase I/II clinical trials for the treatment of urinary incontinence with autologous mesenchymal stem cells.
Clinical Trial with a reported sample of 9, published in Stem Cells Transl Med (2020) — summary generated from the PubMed abstract.
- 2020
- n = 9
Stem Cells Transl Med30 citations - Level BClinical TrialEurope PMC
Autologous mesenchymal stromal cells embedded in tricalcium phosphate for posterolateral spinal fusion: results of a prospective phase I/II clinical trial with long-term follow-up
Clinical Trial on Disc Degeneration, published in Stem Cell Res Ther (2019) — summary generated from the PubMed abstract.
- 2019
Stem Cell Res Ther44 citations - Level BRandomized Controlled TrialPubMed
Intra-Articular Injection of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis: A Phase IIb, Randomized, Placebo-Controlled Clinical Trial.
Randomized Controlled Trial with a reported sample of 12 on Knee Osteoarthritis, Osteoarthritis, Cartilage Damage, published in Stem Cells Transl Med (2019) — summary generated from the PubMed abstract.
- 2019
- n = 12
Stem Cells Transl Med366 citations - Level BClinical TrialPubMed
Intra-arterial renal infusion of autologous mesenchymal stem cells for treatment of chronic kidney disease in cats: Phase I clinical trial.
Clinical Trial on Chronic Kidney Disease, published in J Vet Intern Med (2019) — summary generated from the PubMed abstract.
- 2019
J Vet Intern Med17 citations - Level BRandomized Controlled TrialPubMed
Treatment of knee osteoarthritis with intra-articular injection of autologous adipose-derived mesenchymal progenitor cells: a prospective, randomized, double-blind, active-controlled, phase IIb clinical trial.
Randomized Controlled Trial on Knee Osteoarthritis, Osteoarthritis, Cartilage Damage, Immune Modulation, published in Stem Cell Res Ther (2019) — summary generated from the PubMed abstract.
- 2019
Stem Cell Res Ther
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406